Fusions of catalytically inactive RusA to FokI nuclease coupled with PNA enable programable site-specific double-stranded DNA breaks

Magdy Mahfouz,Ahmed Saleh,Gundra Sivakrishna Rao,Qiaochu Wang
DOI: https://doi.org/10.1101/2024.12.03.626739
2024-12-07
Abstract:Programmable site-specific nucleases have revolutionized the genome editing. However, these systems still face challenges such as guide dependency, delivery issues, and off-target effects. Harnessing the natural functions of structure-guided nucleases offer promising alternatives for generating site-specific double-strand DNA breaks. Yet, structure-guided nucleases require precise reaction conditions and validation for in-vivo applicability. To address these limitations, we developed the PNA-Coupled FokI-(d)RusA (PC-FIRA) system. PC-FIRA combines the sequence-specific binding ability of peptide nucleic acids (PNAs) with the catalytic efficiency of FokI nuclease fused to a structurally-guided inactive RusA resolvase (FokI-(d)RusA). This system allows for precise double-strand DNA breaks without the constraints of existing site-specific nuclease and structure-guided nucleases. Through in vitro optimizations, we achieved high target specificity and cleavage efficiency. This included adjusting incubation temperature, buffer composition, ion concentration, and cleavage timing. Diverse DNA structures, such as Holliday Junctions, linear, and circular DNA, were tested demonstrating the potential activity on different target forms. Further investigation has revealed the PC-FIRA system capacity for facilitating the precise deletion of large DNA fragments. This can be useful in cloning, large-fragment DNA assembly, and genome engineering, with promising applications in biotechnology, medicine, agriculture, and synthetic biology.
Bioengineering
What problem does this paper attempt to address?
The main problems that this paper attempts to solve are the limitations of existing gene - editing tools (such as the CRISPR - Cas system) in terms of specificity, delivery, and off - target effects. Specifically: 1. **Limitations of existing gene - editing tools**: - The CRISPR - Cas technology depends on specific PAM sequences, which restricts its use in PAM - independent applications. - Problems such as large size, unstable sgRNA, and cell membrane barriers limit its delivery efficiency. - Existing site - specific nucleases (SSNs) still have guide - dependence, delivery problems, and off - target effects. 2. **Application challenges of structure - guided nucleases (SGNs)**: - Although structure - guided nucleases have potential, they require precise reaction conditions and need to have their in - vivo applicability verified. - Some structure - guided nucleases lack structural specificity and may lead to off - target activity. To solve these problems, researchers have developed a new system - the **PNA - Coupled FokI - (d)RusA (PC - FIRA)** system. This system combines the sequence - specific binding ability of peptide nucleic acids (PNAs) and the catalytic efficiency of FokI nuclease and inactivated RusA helicase (FokI - (d)RusA) to achieve precise double - stranded DNA breaks (DSBs). By optimizing reaction conditions (such as temperature, buffer composition, ion concentration, and cleavage time), the researchers achieved high target specificity and cleavage efficiency. ### Innovation points of the PC - FIRA system - **Combining the specific binding ability of PNAs**: PNAs can form stable sequence - specific bindings, mimicking Holliday Junctions (HJs) structures, enabling RusA to recognize and bind to these structures. - **Utilizing the highly efficient catalytic ability of FokI**: The FokI nuclease provides highly efficient double - stranded DNA cleavage ability, ensuring the precision and efficiency of cleavage. - **Avoiding the limitations of existing tools**: The PC - FIRA system can be tested on different DNA structures (such as linear and circular DNA), demonstrating its potential activity on different target forms. ### Potential applications The PC - FIRA system performs excellently in cloning, large - fragment DNA assembly, and genome engineering, and has broad application prospects, especially in the fields of biotechnology, medicine, agriculture, and synthetic biology.